Notes - Consolidated Statement Of Income

TOWA PHARMACEUTICAL CO.,LTD. - Filing #7325311

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2022-04-01 to
2023-03-31
Notes - Consolidated statement of income
Notes - Consolidated statement of income
Notes regarding amount of revenue from contracts with customers

1 顧客との契約から生じる収益

売上高については顧客との契約から生じる収益及びそれ以外の収益を区分して記載しておりません顧客との契約から生じる収益の金額は連結財務諸表注記事項(収益認識関係)1.顧客との契約から生じる収益を分解した情報に記載しております

Notes regarding write-downs of inventories
Write-downs of inventories
720,000,000 JPY
992,000,000 JPY
Major components of selling, general and administrative expenses
Research and development expenses included in general and administrative expenses and manufacturing costs for period
Notes regarding impairment losses
Notes regarding gain on sale of property, plant and equipment

Talk to a Data Expert

Have a question? We'll get back to you promptly.